Discover our

Services for Media

Are you a media representative looking for content on Bayer? This section provides news, press photos and more.

June 01, 2023
Not intended for U.S. and UK Media

Bayer starts phase II/III study with vericiguat in children with heart failure

June 01, 2023
Not intended UK Media

Bayer to acquire exclusive license from Cedilla Therapeutics on selective inhibitors in pre-clinical precision oncology

May 31, 2023
Digital health solutions to drive transformation of everyday health:

Bayer launches unit to develop new precision health consumer products


June 20, 2023

August 08, 2023

Q2 2023 Results / Half-Year Report

November 08, 2023

Q3 2023 Results / Quarterly Statement